Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis

Journal of Neuroimmunology

Volumn 287, Issue , 2015, Pages 36-42

  Kevin Li Chun, Hsieh ^a,c,d   Schob, Stefan ^a   Zeller, Matthias W G ^a   Pulli, Benjamin ^a   Ali, Muhammad ^a   Wang, Cuihua ^a   Chiou, Terry Ting Yu ^a   Tsang, Yuk Ming ^b   Lee, Po Shun ^a   Stossel, Thomas P ^a   Chen, John W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Actin; Experimental autoimmune encephalomyelitis (EAE); Gelsolin; Inflammation; Magnetic resonance imaging; Myeloperoxidase

Indexed keywords

ACTIN; GELSOLIN; MYELOPEROXIDASE; RECOMBINANT HUMAN GELSOLIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; CD11B ANTIGEN; FREUND ADJUVANT; MYELIN PROTEOLIPID PROTEIN (139-151); PEPTIDE FRAGMENT; PEROXIDASE; PROTEOLIPID PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME LOCALIZATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; GELSOLIN BLOOD LEVEL; MOUSE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; ANIMAL; BRAIN; DISEASE MODEL; DRUG EFFECTS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLIOMA; HUMAN; IMMUNOLOGY; METABOLISM; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; PATHOLOGY; TIME FACTOR; TUMOR CELL LINE;

ACTINS; ANIMALS; ANTIGENS, CD11B; BRAIN; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FREUND'S ADJUVANT; GELSOLIN; GLIOMA; HUMANS; MICE; MULTIPLE SCLEROSIS; MYCOBACTERIUM TUBERCULOSIS; MYELIN PROTEOLIPID PROTEIN; NEUTROPHILS; PEPTIDE FRAGMENTS; PEROXIDASE; TIME FACTORS;

EID: 84943227874     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.08.006     Document Type: Article

References (36)

1. Accinni L., Natali P.G., Silvestrini M., De Martino C. Actin in the extracellular matrix of smooth muscle cells. An immunoelectron microscopic study. Connect. Tissue Res. 1983, 11:69-78.
2. Breckwoldt M.O., Chen J.W., Stangenberg L., Aikawa E., Rodriguez E., Qiu S., et al. Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:18584-18589.
3. Bruck W. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J. Neurol. 2005, 252(Suppl. 5):v3-v9.
4. Chen J.W., Breckwoldt M.O., Aikawa E., Chiang G., Weissleder R. Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis. Brain 2008, 131:1123-1133.
5. Chou S.H., Lee P.S., Konigsberg R.G., Gallacci D., Chiou T., Arai K., et al. Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage. Stroke 2011, 42:3624-3627.
6. Erukhimov J.A., Tang Z.L., Johnson B.A., Donahoe M.P., Razzack J.A., Gibson K.F., et al. Actin-containing sera from patients with adult respiratory distress syndrome are toxic to sheep pulmonary endothelial cells. Am. J. Respir. Crit. Care Med. 2000, 162:288-294.
7. Forghani R., Wojtkiewicz G.R., Zhang Y., Seeburg D., Bautz B.R., Pulli B., et al. Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target. Radiology 2012, 263:451-460.
8. Frohman E.M., Racke M.K., Raine C.S. Multiple sclerosis - the plaque and its pathogenesis. N. Engl. J. Med. 2006, 354:942-955.
9. Greer J.M., Sobel R.A., Sette A., Southwood S., Lees M.B., Kuchroo V.K. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J. Immunol. 1996, 156:371-379.
10. Haddad J.G., Harper K.D., Guoth M., Pietra G.G., Sanger J.W. Angiopathic consequences of saturating the plasma scavenger system for actin. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:1381-1385.
11. Heinecke J.W. Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders. J. Lab. Clin. Med. 1999, 133:321-325.
12. Hofstein R., Hesse G., Shashoua V.E. Proteins of the extracellular fluid of mouse brain: extraction and partial characterization. J. Neurochem. 1983, 40:1448-1455.
13. Imitola J., Chitnis T., Khoury S.J. Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapies. Arch. Neurol. 2006, 63:25-33.
14. Klebanoff S.J. Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science 1970, 169:1095-1097.
15. Kulakowska A., Ciccarelli N.J., Wen Q., Mroczko B., Drozdowski W., Szmitkowski M., et al. Hypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosis. BMC Neurol. 2010, 10:107.
16. Kwiatkowski D.J., Mehl R., Izumo S., Nadal-Ginard B., Yin H.L. Muscle is the major source of plasma gelsolin. J. Biol. Chem. 1988, 263:8239-8243.
17. 2+ requirement. J. Biol. Chem. 1993, 268:8999-9004.
18. Lee W.M., Galbraith R.M. The extracellular actin-scavenger system and actin toxicity. N. Engl. J. Med. 1992, 326:1335-1341.
19. Lee P.S., Waxman A.B., Cotich K.L., Chung S.W., Perrella M.A., Stossel T.P. Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit. Care Med. 2007, 35:849-855.
20. Lind S.E., Smith D.B., Janmey P.A., Stossel T.P. Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation. J. Clin. Invest. 1986, 78:736-742.
21. Lind S.E., Smith D.B., Janmey P.A., Stossel T.P. Depression of gelsolin levels and detection of gelsolin-actin complexes in plasma of patients with acute lung injury. Am. Rev. Respir. Dis. 1988, 138:429-434.
22. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 2000, 343:938-952.
23. Osborn T.M., Dahlgren C., Hartwig J.H., Stossel T.P. Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Am. J. Physiol. Cell Physiol. 2007, 292:C1323-C1330.
24. Pulli B., Ali M., Forghani R., Schob S., Hsieh K.L., Wojtkiewicz G., et al. Measuring myeloperoxidase activity in biological samples. PLoS One 2013, 8:e67976.
25. Pulli B., Bure L., Wojtkiewicz G.R., Iwamoto Y., Ali M., Li D., et al. Multiple sclerosis: myeloperoxidase immunoradiology improves detection of acute and chronic disease in experimental model. Radiology 2015, 275:480-489.
26. Semra Y.K., Seidi O.A., Sharief M.K. Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability. J. Neuroimmunol. 2002, 122:132-139.
27. Silacci P., Mazzolai L., Gauci C., Stergiopulos N., Yin H.L., Hayoz D. Gelsolin superfamily proteins: key regulators of cellular functions. Cell. Mol. Life Sci. 2004, 61:2614-2623.
28. Smith D.B., Janmey P.A., Herbert T.J., Lind S.E. Quantitative measurement of plasma gelsolin and its incorporation into fibrin clots. J. Lab. Clin. Med. 1987, 110:189-195.
29. Tanaka J., Kira M., Sobue K. Gelsolin is localized in neuronal growth cones. Brain Res. Dev. Brain Res. 1993, 76:268-271.
30. Teunissen C.E., Dijkstra C., Polman C. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol. 2005, 4:32-41.
31. Toft-Hansen H., Fuchtbauer L., Owens T. Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease. Glia 2011, 59:166-176.
32. Voskuhl R.R., Peterson R.S., Song B., Ao Y., Morales L.B., Tiwari-Woodruff S., et al. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J. Neurosci. Off. J. Soc. Neurosci. 2009, 29:11511-11522.
33. Wen D., Corina K., Chow E.P., Miller S., Janmey P.A., Pepinsky R.B. The plasma and cytoplasmic forms of human gelsolin differ in disulfide structure. Biochemistry 1996, 35:9700-9709.
34. Yin H.L., Stossel T.P. Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein. Nature 1979, 281:583-586.
35. 2+ control of actin gelation. Interaction of gelsolin with actin filaments and regulation of actin gelation. J. Biol. Chem. 1980, 255:9494-9500.
36. Yin H.L., Kwiatkowski D.J., Mole J.E., Cole F.S. Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J. Biol. Chem. 1984, 259:5271-5276.